ArticleEuropean heart journal2020

Persistent inflammatory residual risk despite aggressive cholesterol-lowering therapy: further evidence fuelling the dual target concept.

Wolfgang KoenigPubMed ↗Publisher ↗

No numbers read from the abstract.